Retinopathy of prematurity (rop) Clinical Trials
Conditions / Retinopathy of prematurity (rop)
Delta Trials records 20 clinical trials for Retinopathy of prematurity (rop) in its publicly accessible dataset. From the full dataset, 5 actively seeking eligible participants and 9 trials have reached completion. This research is conducted across 229 study locations around the world. An additional 6 trials are active but not currently open for enrollment. Since 2020, 2 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
20
Total Trials
5
Recruiting
9
Completed
6
Other Active
2
Terminated since 2020
229
Study Locations
Browse by location (229 total)
- Florence, Italy 5 trialsAll trials in Florence, Italy
- Chertsey, United Kingdom 4 trialsAll trials in Chertsey, United Kingdom
- Genova, Italy 4 trialsAll trials in Genova, Italy
- Rome, Italy 4 trialsAll trials in Rome, Italy
- Lund, Sweden 4 trialsAll trials in Lund, Sweden
- Rochester, United States 3 trialsAll trials in Rochester, United States
- Fuchū, Japan 3 trialsAll trials in Fuchū, Japan
- Athens, Greece 3 trialsAll trials in Athens, Greece
- Oklahoma City, United States 3 trialsAll trials in Oklahoma City, United States
- Jackson, United States 3 trialsAll trials in Jackson, United States
- Prague, Czechia 3 trialsAll trials in Prague, Czechia
- Shimajiri-gun, Japan 3 trialsAll trials in Shimajiri-gun, Japan
- Saint Petersburg, Russia 3 trialsAll trials in Saint Petersburg, Russia
- Perugia, Italy 3 trialsAll trials in Perugia, Italy
- Padua, Italy 3 trialsAll trials in Padua, Italy
- Bruges, Belgium 3 trialsAll trials in Bruges, Belgium
- Toshima Ku, Japan 3 trialsAll trials in Toshima Ku, Japan
- Athens, Greece 3 trialsAll trials in Athens, Greece
- Kurume, Japan 3 trialsAll trials in Kurume, Japan
- Taipei, Taiwan 3 trialsAll trials in Taipei, Taiwan